1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. SENTI BIOSCIENCES INC.

Senti Biosciences Inc.

XNAS: SNTI

Download real time

3.62 -0.03 (-0.82%)

78.63% Fall from 52W High

20,847 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
11W
0O
1T
17.5

Market Cap

Low in industry
-0.2

PE TTM

Negative PE TTM
0.5

PEG TTM

PEG TTM is less than 1
1.1

Price to Book

Below industry Median
-0.9

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Senti Biosciences Inc. is on 21 Mar 2025 for the purpose of Senti Biosciences Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Senti Biosciences Inc.

The latest disclosure was made by Kanya Rajangam in Senti Biosciences Inc. where a trade of 33 Series A Convertible Preferred Stock done was reported to US exchanges on March 10, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kanya Rajangam Pres. & Chief Med. & Dev. Off. 10 Mar 2025 33 0 - - Series A Convertible Preferred Stock
Kanya Rajangam Pres. & Chief Med. & Dev. Off. 10 Mar 2025 33,000 33,000 - 2.3 74,250 Common Stock
Feng Hsiung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
Frances D. Schulz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
James J. Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
Timothy Lu Director, CEO and Interim PFO and PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 1,927,073 1,927,073 - - Stock Option (Right to Buy)
Timothy Lu Director, CEO and Interim PFO and PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 642,358 724,440 - 0 Common Stock
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 235,088 235,088 - - Stock Option (Right to Buy)
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 78,363 86,984 - 0 Common Stock
Timothy Lu Director, CEO Sale of securities on an exchange or to another person at price $ 4.36 per share. 04 Feb 2025 545 82,082 - 4.4 2,376 Common Stock
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Sale of securities on an exchange or to another person at price $ 4.07 per share. 04 Feb 2025 1,297 8,803 - 4.1 5,279 Common Stock
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Sale of securities on an exchange or to another person at price $ 4.37 per share. 04 Feb 2025 182 8,621 - 4.4 795 Common Stock
Timothy Lu Director, CEO Sale of securities on an exchange or to another person at price $ 4.07 per share. 04 Feb 2025 3,922 82,627 - 4.1 15,963 Common Stock
Frances Schulz D. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 12,500 12,500 - - Stock Option (Right to Buy)
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 49,500 49,500 - - Common Stock Warrant (right to buy)
Kanya Rajangam Pres. & Chief Med. & Dev. Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 33 33 - - Series A Convertible Preferred Stock
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2024 62,500 62,500 - - Stock Option (Right to Buy)
James J. Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2024 62,500 62,500 - - Stock Option (Right to Buy)
Omid Farokhzad Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2024 62,500 62,500 - - Stock Option (Right to Buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2024 62,500 62,500 - - Stock Option (Right to Buy)
Knobelman Deborah Chief Financial Officer, Head of Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 152,000 152,000 - - Stock Option (Right to Buy)
Rajangam Kanya Chief Medical & Devt. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 101,000 101,000 - 0 Common Stock
Rajangam Kanya Chief Medical & Devt. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 152,000 152,000 - - Stock Option (Right to Buy)
Timothy Lu Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 459,000 459,000 - - Stock Option (Right to Buy)
Lu Timothy Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 306,000 865,496 - 0 Common Stock
Deborah Knobelman Chief Financial Officer, Head of Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 101,000 131,000 - 0 Common Stock
Susan D. Berland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
Omid Farokhzad Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
James J. Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
Kanya Rajangam Chief Medical & Devt. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 130,000 130,000 - - Stock Option (Right to Buy)
Timothy Lu Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 630,000 630,000 - - Stock Option (Right to Buy)
Deborah Knobelman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 130,000 130,000 - - Stock Option (Right to Buy)
Philip Lee Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 195,000 195,000 - - Stock Option (Right to Buy)
Deborah Knobelman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2022 240,000 240,000 - - Stock Option (Right to Buy)
Deborah Knobelman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2022 30,000 30,000 - 0 Common Stock
Kanya Rajangam Chief Medical & Devt. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2022 327,750 327,750 - - Stock Option (Right to Buy)
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
James J. Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
Omid Farokhzad Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
Susan D. Berland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
David R. Epstein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2022 112,519 0 - - Class B Common Stock
David R. Epstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 112,519 123,252 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters